CAS 39247-61-5

5,6,7,8-tetrahydro[1,2,4]triazolo[5,1-b]quinazolin-9(4H)-one

Description:

5,6,7,8-tetrahydro[1,2,4]triazolo[5,1-b]quinazolin-9(4H)-one is a heterocyclic compound characterized by its complex bicyclic structure, which incorporates both triazole and quinazoline moieties. This compound typically exhibits a range of biological activities, making it of interest in medicinal chemistry and pharmacology. Its molecular structure includes a fused triazole ring and a quinazolinone, contributing to its potential as a scaffold for drug development. The presence of nitrogen atoms in the rings can influence its reactivity and solubility, while the tetrahydro configuration suggests it is a saturated derivative, which may enhance its stability and bioavailability. The compound is often studied for its potential therapeutic applications, including anti-inflammatory and anticancer properties. Additionally, its unique structural features may allow for interactions with various biological targets, making it a subject of interest in the development of novel pharmaceuticals. As with many heterocycles, the specific properties such as melting point, solubility, and spectral characteristics would depend on the conditions and methods used for characterization.

Formula: C₉H₁₀N₄O

Synonyms:

• 5,6,7,8-tetrahydro[1,2,4]triazolo[5,1-b]quinazolin-9(4H)-one
• [1,2,4]Triazolo[5,1-b]quinazolin-9(1H)-one, 5,6,7,8-tetrahydro-
• 4H,5H,6H,7H,8H,9H-[1,2,4]triazolo[3,2-b]quinazoli n-9-one

4H,5H,6H,7H,8H,9H-[1,2,4]Triazolo[3,2-b]quinazolin-9-one

CAS: 39247-61-5

Versatile small molecule scaffold

Formula: C₉H₁₀N₄O

Purity: Min. 95%

Molecular weight: 190.2 g/mol

Ref: 3D-PBA24761